126 related articles for article (PubMed ID: 1706617)
1. Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells.
Resnitzky D; Kimchi A
Cell Growth Differ; 1991 Jan; 2(1):33-41. PubMed ID: 1706617
[TBL] [Abstract][Full Text] [Related]
2. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells.
Resnitzky D; Tiefenbrun N; Berissi H; Kimchi A
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):402-6. PubMed ID: 1370354
[TBL] [Abstract][Full Text] [Related]
3. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells.
Tiefenbrun N; Kimchi A
Oncogene; 1991 Jun; 6(6):1001-7. PubMed ID: 1712443
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
Goya L; Maiyar AC; Ge Y; Firestone GL
Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
[TBL] [Abstract][Full Text] [Related]
5. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative.
Melamed D; Resnitzky D; Haimov I; Levy N; Pfarr CM; Yaniv M; Kimchi A
Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.
Hoffman-Liebermann B; Liebermann DA
Mol Cell Biol; 1991 May; 11(5):2375-81. PubMed ID: 1901940
[TBL] [Abstract][Full Text] [Related]
8. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
Askew DS; Ashmun RA; Simmons BC; Cleveland JL
Oncogene; 1991 Oct; 6(10):1915-22. PubMed ID: 1923514
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
10. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
Gibbs JD; Liebermann DA; Hoffman B
Leukemia; 2008 Oct; 22(10):1909-16. PubMed ID: 18650844
[TBL] [Abstract][Full Text] [Related]
11. Cytokine triggered molecular pathways that control cell cycle arrest.
Kimchi A
J Cell Biochem; 1992 Sep; 50(1):1-9. PubMed ID: 1385455
[TBL] [Abstract][Full Text] [Related]
12. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression.
Levy N; Yonish-Rouach E; Oren M; Kimchi A
Mol Cell Biol; 1993 Dec; 13(12):7942-52. PubMed ID: 8247009
[TBL] [Abstract][Full Text] [Related]
13. Transfection of fibroblasts with activated c-myc confers resistance to antigrowth effects of interferon.
Einat M; Kimchi A
Oncogene; 1988 May; 2(5):485-91. PubMed ID: 2453829
[TBL] [Abstract][Full Text] [Related]
14. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
Selvakumaran M; Liebermann D; Hoffman-Liebermann B
Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
[TBL] [Abstract][Full Text] [Related]
15. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
16. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest.
Vairo G; Vadiveloo PK; Royston AK; Rockman SP; Rock CO; Jackowski S; Hamilton JA
Oncogene; 1995 May; 10(10):1969-76. PubMed ID: 7761098
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
19. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
